Related Experiment Videos
Vitreous cavity-associated immune deviation induced by retinal S antigen
1Department of Ophthalmology, Institute of Tissue Transplantation & Immunology Jinan University, Guangzhou 510632.
Yan Ke Xue Bao = Eye Science
|February 6, 2003
Summary
The vitreous cavity (VC) normally suppresses immune responses to retinal soluble antigen. Systemic interleukin-1 (IL-1) administration blocks this immune deviation, promoting a strong immune response.
Area of Science:
- Ophthalmology
- Immunology
- Retinal research
Background:
- The eye's immune privilege is crucial for vision.
- Understanding immune responses within the eye is vital for treating ocular inflammatory diseases.
Purpose of the Study:
- To investigate if the vitreous cavity (VC) induces immune deviation to retinal soluble antigen.
- To determine the effect of interleukin-1 (IL-1) on the immunologic properties of the VC.
Main Methods:
- Retinal soluble antigen was injected into the anterior chamber (AC) and VC of Wistar rats.
- Animals were subsequently immunized with antigen and complete Freund's adjuvant.
- Delayed-type hypersensitivity (DTH) was measured, and IL-1 was administered intraperitoneally.
Main Results:
- Injection of antigen into the AC and VC did not induce antigen-specific DTH.
- Systemic IL-1 administration, however, led to strong DTH responses when antigen was injected into the AC and VC.
Conclusions:
- The VC promotes immune deviation, suppressing antigen-specific DTH for locally injected soluble antigens.
- Exogenous systemic IL-1 abrogates the VC's ability to induce immune deviation to locally injected soluble antigens.